Captopril
38 NDCs across 8 manufacturers|38 Generic,0 Brand
Captopril is used to treat rheumatoid arthritis, bartter syndrome, diabetic nephropathies, edema, heart failure and malignant hypertension, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Mar 31, 1995. FDA's Orange Book lists 28 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $5 million on Captopril across 71,000 claims for 17,000 beneficiaries.
Captopril is available as 38 NDCs from 8 manufacturers (38 generic, 0 brand), with NADAC prices from $0.17 to $0.37 per EA — the most expensive product costs about 2.1× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
38
38G / 0B
Manufacturers
8
competing in market
Price Spread
$0.17 – $0.37
per EA
7d Activity
avg +5.0% WoW · of 38 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Amici Pharmaceuticals LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Angiotensin Converting Enzyme Inhibitor class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
8 manufacturers producing CAPTOPRIL(2 pricing outliers)
Frequently Asked Questions
What is Captopril used to treat?
Captopril is used to treat rheumatoid arthritis, bartter syndrome, diabetic nephropathies, edema, heart failure and malignant hypertension, per the National Library of Medicine's MED-RT classification.
When did Captopril become available as a generic?
FDA approved the first generic Captopril (ANDA) on Mar 31, 1995. The Orange Book currently lists 28 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Captopril?
In 2024, Medicare Part D spent $5 million on Captopril across 71,000 claims for 17,000 beneficiaries.
How many Captopril products are on the market?
The Captopril drug market contains 38 NDCs from 8 manufacturers — 38 generic and 0 brand products.
What is the price range for Captopril?
NADAC reference prices for Captopril range from $0.1728 to $0.3690 per EA — the most expensive product costs about 2.1× the cheapest.
Which manufacturers make Captopril?
8 manufacturers list Captopril in NADAC. Ranked by number of NDCs, the largest are Amici Pharmaceuticals LLC (8), Ajanta Pharma USA Inc. (7), Hikma Pharmaceuticals USA Inc. (7), Camber Pharmaceuticals Inc. (4), Solco Healthcare US LLC (4).
How has the price of Captopril changed recently?
Over the past 7 days, 8 Captopril NDCs rose and 20 fell, with a market-wide average change of +5.0%.